✦ LIBER ✦

A phase II study of cediranib as palliative treatment in patients with symptomatic malignant ascites or pleural effusion

✍ Scribed by Mulder, S. F.; Boers-Sonderen, M. J.; van der Heijden, H. F. M.; Vissers, K. C. P.; Punt, C. J. A.; van Herpen, C. M. L.

Book ID: 121569098
Publisher: Springer-Verlag
Year: 2014
Tongue: English
Weight: 238 KB
Volume: 9
Category: Article
ISSN: 1776-2596
DOI: 10.1007/s11523-014-0306-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of aflibercept in patie

A phase II study of aflibercept in patients with advanced epithelial ovarian cancer and symptomatic malignant ascites

✍ Nicoletta Colombo; Giorgia Mangili; Serafina Mammoliti; Mårten Kalling; Bengt Th 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 260 KB

A phase II study of gemcitabine in patie

A phase II study of gemcitabine in patients with malignant pleural mesothelioma

✍ Jan P. van Meerbeeck; Paul Baas; Channa Debruyne; Harry J. Groen; Chris Manegold 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## BACKGROUND. Gemcitabine has shown activity in patients with less chemosensitive solid tumors. Phase II screening of novel drugs is an accepted method with which to investigate new therapies in malignant mesothelioma. The European Organization for Research and Treatment of Cancer-Lung Cancer Coo

Carboplatin Plus Pemetrexed as First-lin

Carboplatin Plus Pemetrexed as First-line Treatment of Patients With Malignant Pleural Mesothelioma: A Phase II Study

✍ Nikolaos Katirtzoglou; Ioannis Gkiozos; Nektaria Makrilia; Emilia Tsaroucha; Agg 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 349 KB

Intrathoracic hypotonic CDDP treatment (

Intrathoracic hypotonic CDDP treatment (HPT) for malignant pleural effusion in patients with non-small cell lung cancer (NSCLC). A phase II study

✍ Ichinose, Y; Seto, T; Senba, H; Yamamoto, H; Ushijima, S; Araki, J; Inoue, Y; It 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 108 KB

A phase II EORTC study of temozolomide i

A phase II EORTC study of temozolomide in patients with malignant pleural mesothelioma

✍ J.P. van Meerbeeck; P. Baas; C. Debruyne; E.F. Smit; R.J. van Klaveren; D. Galde 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 130 KB

86 A phase I feasibility and pharmacokin

86 A phase I feasibility and pharmacokinetic study of intrapleural paclitaxel in patients with malignant pleural effusions

✍ Perng, R.-P.; Wu, M.-F.; Lin, S.-Y.; Chen, Y.-M.; Lin, J.-Y.; Whang-Peng, J. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 132 KB